by Lisa Willemse | Apr 25, 2013
Co-authored with Geoff Lomax, CIRM’s Senior Officer to the Standards Working Group from the “Understanding Stem Cell Controversies” Workshop organized by the Stem Cell Network in Montreal. This article is cross-posted on the CIRM blog. The afternoon session on Day 2...
by Lisa Willemse | Apr 24, 2013
Co-authored with Geoff Lomax, CIRM’s Senior Officer to the Standards Working Group from the “Understanding Stem Cell Controversies” Workshop organized by the Stem Cell Network in Montreal. This article is cross-posted on the CIRM blog. “Stem cell...
by Ubaka Ogbogu | Feb 26, 2013
Patients contemplating medical travel for the purpose of receiving scientifically unproven stem cell treatments may wish to consider one more potential side effect: the possibility of losing their eligibility for health status-related compensation and benefits. In May...
by Angela C. H. McDonald | Nov 27, 2012
Last month, I blogged about recent stem cell advances toward a solution for female infertility. While this post may have left you excited about the potential for stem cells to help women with fertility complications start a family, it may also have left you wondering:...
by Stacey Johnson | Oct 26, 2012
On the same day that I learned the (disturbing and sad) news that a friend, a woman in her early 40s, has a pacemaker, I read that a stem cell scientist in cardiovascular medicine, at the University of California, has received a grant to develop stem cells that...
by Angela C. H. McDonald | Sep 11, 2012
You don’t have to follow pharmaceutical industry news to know that this summer has been a disappointing one for Alzheimer’s research. Many major media outlets covered the failure of potential Alzheimer’s drug bapineuzumab (Pfizer/Johnson & Johnson) in Phase II/III...
Comments